Navigation Links
New Mexico Software Prevails in Lawsuit

ALBUQUERQUE, N.M., Feb. 28, 2012 /PRNewswire/ -- New Mexico Software, Inc., d/b/a Net Medical Xpress (OTC Bulletin Board: NMXC), a developer of medical IT solutions and services that enable improved and faster communication within the healthcare community, announced today that the company's long standing suit brought by Premier Medical Enterprise Solutions, Inc. has been concluded with judgment in favor of New Mexico Software.

The court ordered that all claims brought by Premier Medical against New Mexico Software and/or Richard Govatski, its CEO, be dismissed. In addition, the court granted a judgment in favor of New Mexico Software on liability in its counterclaim for $636,605.88. The claims for damages against New Mexico Software were denied.

Govatski said, "We are pleased to have this action against us settled in our favor. We are reviewing our options on collection actions and we will pursue this judgment further."

About Net Medical Xpress, a trade name of New Mexico Software, Inc.

Net Medical Xpress develops and provides medical IT services and solutions that enable improved and faster communication within the preventative, comprehensive and critical healthcare segments. For more information, visit or or contact Dick Govatski, president and CEO, at 505-255-1999 or

An investment profile on New Mexico Software may be found at To receive future releases in e-mail alerts, sign up at

For more investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.

SOURCE New Mexico Software, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
2. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
3. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
4. The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak
5. Takeda to Establish Four Sales and Marketing Subsidiaries to Expand Its Operations in Mexico, Turkey and Five Other Countries in Europe
6. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
7. Misonix Announces New Distribution Agreement for Mexico
8. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
9. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
10. Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
11. Exagens Corporate Expansion Creates Job Opportunities in New Mexico
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... Nov. 25, 2015 AAIPharma Services Corp./Cambridge ... of at least $15.8  Million to expand its ... NC . The expansion will provide additional ... the growing demands of the pharmaceutical and biotechnology ... expansion will provide up to 40,000 square feet ...
(Date:11/25/2015)... MELVILLE, N.Y. , Nov. 25, 2015  Henry ... products and services to office-based dental, medical and animal ... Dental (GNYDM) Meeting the Henry Schein ConnectDental® Pavilion ... industry,s broadest array of open solutions designed to help ... Click here for a schedule of ...
Breaking Medicine Technology:
(Date:11/25/2015)... Ill. (PRWEB) , ... November 25, 2015 , ... ... and potentially more aggressive than those found on mammography, according to a study ... findings of additional cancers not seen on mammography may necessitate a change in ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday season ... and pleasing the palates of attendees is of the utmost importance. Whether you ... seasonal get-together, give these recipes a try this holiday season. , Turkey Croquettes ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... recognized once again for its stellar workplace culture with the company’s Cincinnati office ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dr. John ... to learn more about hair loss treatment with the Capillus272™ Pro laser therapy cap. ... solution for thicker and fuller hair, without the need for surgery, prescription pills, or ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
Breaking Medicine News(10 mins):